Clinical Trial Results:
A multicenter, randomized, blinded efficacy and safety study of pasireotide LAR vs octreotide LAR in patients with metastatic carcinoid tumors whose disease-related
symptoms are inadequately controlled by somatostatin analogues
Summary
|
|
EudraCT number |
2007-000739-25 |
Trial protocol |
SE FR DE IT ES GB BE AT NL |
Global completion date |
19 Apr 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
03 Apr 2016
|
First version publication date |
03 Apr 2016
|
Other versions |
|
Summary report(s) |
CSOM230C2303_CT_gov_results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.